title: A novel means to demonstrate early efficacy of a product in systemic lupus erythematosus.
authors.affiliation: Division of Immunology, Stanford University, 300 Pasteur Drive, Stanford, CA 94305, USA. vstrand@stanford.edu
authors.forename: Vibeke
authors.initials: V
authors.lastname: Strand
mesh_terms: D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology; D016032:Randomized Controlled Trials as Topic; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D000276:Adjuvants, Immunologic